Recent Advances in Understanding the Pathogenesis of Cardiovascular Diseases and Development of Treatment Modalities

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Pathology

Background:

• Cardiovascular Diseases (CVDs) represent a major global health burden, primarily driven by atherosclerosis.
• Atherosclerosis involves a progressive process including fatty streak formation, plaque development, and eventual plaque rupture.
• Current treatments for CVD face limitations due to inherent drug delivery obstacles.

Purpose of the Study:

• To review the pathogenesis of atherosclerosis, the primary underlying mechanism of most CVDs.
• To outline the first-line medical treatments currently employed for managing CVD.
• To identify and discuss key challenges and obstacles hindering efficient drug delivery for CVD.

Main Methods:

• Literature review of atherosclerosis pathogenesis.
• Analysis of current first-line medical therapies for CVD.
• Identification and discussion of drug delivery challenges in CVD treatment.

Main Results:

• Atherosclerosis is a complex, multi-step pathological process.
• Standard medical therapies exist but are hampered by drug delivery inefficiencies.
• Understanding these limitations is key to advancing CVD pharmacotherapeutics.

Conclusions:

• Developing novel therapeutic targets for CVD requires a comprehensive understanding of atherosclerotic pathogenesis.
• Overcoming drug delivery obstacles is essential for improving the efficacy of CVD treatments.
• Further investigation into molecular mechanisms and drug delivery systems is warranted for better CVD management.